Friday, October 28, 2016

Deltamannit




Deltamannit may be available in the countries listed below.


Ingredient matches for Deltamannit



Mannitol

Mannitol is reported as an ingredient of Deltamannit in the following countries:


  • Germany

International Drug Name Search


Septeal




Septeal may be available in the countries listed below.


Ingredient matches for Septeal



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Septeal in the following countries:


  • Luxembourg

International Drug Name Search


Thursday, October 27, 2016

Diclamina




Diclamina may be available in the countries listed below.


Ingredient matches for Diclamina



Cinnarizine

Cinnarizine is reported as an ingredient of Diclamina in the following countries:


  • Spain

Heptaminol

Heptaminol acefyllinate (a derivative of Heptaminol) is reported as an ingredient of Diclamina in the following countries:


  • Spain

International Drug Name Search


Nizax




Nizax may be available in the countries listed below.


Ingredient matches for Nizax



Nizatidine

Nizatidine is reported as an ingredient of Nizax in the following countries:


  • Italy

International Drug Name Search


Quininga




Quininga may be available in the countries listed below.


Ingredient matches for Quininga



Quinine

Quinine dihydrochloride (a derivative of Quinine) is reported as an ingredient of Quininga in the following countries:


  • India

Quinine sulfate (a derivative of Quinine) is reported as an ingredient of Quininga in the following countries:


  • India

International Drug Name Search


Voltaren Oftalmico




Voltaren Oftalmico may be available in the countries listed below.


Ingredient matches for Voltaren Oftalmico



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Voltaren Oftalmico in the following countries:


  • Chile

  • Peru

International Drug Name Search


Opmun




Opmun may be available in the countries listed below.


Ingredient matches for Opmun



Opipramol

Opipramol dihydrochloride (a derivative of Opipramol) is reported as an ingredient of Opmun in the following countries:


  • Germany

International Drug Name Search


DBL Metronidazole Intravenous Infusion




DBL Metronidazole Intravenous Infusion may be available in the countries listed below.


Ingredient matches for DBL Metronidazole Intravenous Infusion



Metronidazole

Metronidazole is reported as an ingredient of DBL Metronidazole Intravenous Infusion in the following countries:


  • Australia

International Drug Name Search


Diconten




Diconten may be available in the countries listed below.


Ingredient matches for Diconten



Flupentixol

Flupentixol is reported as an ingredient of Diconten in the following countries:


  • Bangladesh

Melitracen

Melitracen is reported as an ingredient of Diconten in the following countries:


  • Bangladesh

International Drug Name Search


Dilabar




Dilabar may be available in the countries listed below.


Ingredient matches for Dilabar



Captopril

Captopril is reported as an ingredient of Dilabar in the following countries:


  • Spain

International Drug Name Search


Septivon




Septivon may be available in the countries listed below.


Ingredient matches for Septivon



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Septivon in the following countries:


  • France

Triclocarban

Triclocarban is reported as an ingredient of Septivon in the following countries:


  • Switzerland

International Drug Name Search


Wednesday, October 26, 2016

Droxil




Droxil may be available in the countries listed below.


Ingredient matches for Droxil



Cefadroxil

Cefadroxil is reported as an ingredient of Droxil in the following countries:


  • Bahrain

  • Iraq

  • Jordan

  • Libya

  • Nicaragua

  • Qatar

  • Saudi Arabia

  • Sudan

  • United Arab Emirates

  • Yemen

Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Droxil in the following countries:


  • Argentina

International Drug Name Search


Duraphat




Duraphat may be available in the countries listed below.


Ingredient matches for Duraphat



Sodium Fluoride

Sodium Fluoride is reported as an ingredient of Duraphat in the following countries:


  • Austria

  • Denmark

  • Finland

  • France

  • Georgia

  • Germany

  • Iceland

  • Israel

  • Italy

  • Norway

  • Poland

  • Sweden

  • Switzerland

International Drug Name Search


Deprofen




Deprofen may be available in the countries listed below.


Ingredient matches for Deprofen



Ibuprofen

Ibuprofen is reported as an ingredient of Deprofen in the following countries:


  • Bangladesh

International Drug Name Search


Diagnogreen




Diagnogreen may be available in the countries listed below.


Ingredient matches for Diagnogreen



Indocyanine Green

Indocyanine Green is reported as an ingredient of Diagnogreen in the following countries:


  • Japan

International Drug Name Search


Tuesday, October 25, 2016

Nystatin Powder




Ingredient matches for Nystatin Powder



Nystatin

Nystatin is reported as an ingredient of Nystatin Powder in the following countries:


  • United States

International Drug Name Search


Hemodialysis Anticoagulation Medications


There are currently no drugs listed for "Hemodialysis Anticoagulation". See Hemodialysis.





Drug List:


Aortic Stenosis Medications


Definition of Aortic Stenosis: The aorta is the large artery that originates in the left ventricle (lower chamber) of the heart. Aortic stenosis is the narrowing or obstruction of the heart´s aortic valve, which prevents it from opening properly and blocks the flow of blood from the left ventricle to the aorta.

Drugs associated with Aortic Stenosis

The following drugs and medications are in some way related to, or used in the treatment of Aortic Stenosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Aortic Stenosis





Drug List:


Head Injury Medications


Definition of Head Injury:

A head injury is any trauma that leads to injury of the scalp, skull, or brain. The injuries can range from a minor bump on the skull to serious brain injury.

Drugs associated with Head Injury

The following drugs and medications are in some way related to, or used in the treatment of Head Injury. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Head Injury

  • Head Injury w/ Intracranial Hemorrhage and Loss of Consciousness (0 drugs)

  • Head Injury with Intracranial Hemorrhage (0 drugs)

  • Head Injury with Loss of Consciousness (0 drugs)

Learn more about Head Injury





Drug List:


Primary Hyperaldosteronism Diagnosis Medications


Drugs associated with Primary Hyperaldosteronism Diagnosis

The following drugs and medications are in some way related to, or used in the treatment of Primary Hyperaldosteronism Diagnosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Dozoltac




Dozoltac may be available in the countries listed below.


Ingredient matches for Dozoltac



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Dozoltac in the following countries:


  • Vietnam

Paracetamol

Paracetamol is reported as an ingredient of Dozoltac in the following countries:


  • Vietnam

International Drug Name Search


Coccidioidomycosis Medications


Definition of Coccidioidomycosis: Coccidiodomycosis is a disease caused by the spores of the fungus,

Drugs associated with Coccidioidomycosis

The following drugs and medications are in some way related to, or used in the treatment of Coccidioidomycosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Coccidioidomycosis

  • Coccidioidomycosis, Meningitis (5 drugs)

  • Coccidioidomycosis, Prophylaxis (0 drugs)

Learn more about Coccidioidomycosis





Drug List:


Vispring




Vispring may be available in the countries listed below.


Ingredient matches for Vispring



Tetryzoline

Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Vispring in the following countries:


  • Spain

International Drug Name Search


Desonate




In the US, Desonate (desonide topical) is a member of the drug class topical steroids and is used to treat Atopic Dermatitis, Dermatitis, Eczema and Psoriasis.

US matches:

  • Desonate

  • Desonate Gel

Ingredient matches for Desonate



Desonide

Desonide is reported as an ingredient of Desonate in the following countries:


  • United States

International Drug Name Search


Sanval




Sanval may be available in the countries listed below.


Ingredient matches for Sanval



Zolpidem

Zolpidem is reported as an ingredient of Sanval in the following countries:


  • Latvia

  • Poland

  • Romania

  • Serbia

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Sanval in the following countries:


  • Bosnia & Herzegowina

  • Croatia (Hrvatska)

  • Hungary

  • Russian Federation

  • Slovakia

  • Slovenia

International Drug Name Search


Sterilene




Sterilene may be available in the countries listed below.


Ingredient matches for Sterilene



Cetrimonium

Cetrimonium tosilate (a derivative of Cetrimonium) is reported as an ingredient of Sterilene in the following countries:


  • Italy

International Drug Name Search


Venofer


Venofer is a brand name of iron sucrose, approved by the FDA in the following formulation(s):


VENOFER (iron sucrose - injectable; intravenous)



  • Manufacturer: LUITPOLD

    Approval date: November 6, 2000

    Strength(s): EQ 100MG BASE/5ML (EQ 20MG BASE/ML) [RLD]


  • Manufacturer: LUITPOLD

    Approval date: March 20, 2005

    Strength(s): EQ 50MG BASE/2.5ML (EQ 20MG BASE/ML)


  • Manufacturer: LUITPOLD

    Approval date: February 9, 2007

    Strength(s): EQ 200MG BASE/10ML (EQ 20MG BASE/ML)

Has a generic version of Venofer been approved?


No. There is currently no therapeutically equivalent version of Venofer available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Venofer. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Venofer.

See also...

  • Venofer Consumer Information (Drugs.com)
  • Venofer Consumer Information (Wolters Kluwer)
  • Venofer injection Consumer Information (Cerner Multum)
  • Venofer AHFS DI Monographs (ASHP)
  • Iron Sucrose Consumer Information (Wolters Kluwer)
  • Iron sucrose injection Consumer Information (Cerner Multum)
  • Iron Sucrose AHFS DI Monographs (ASHP)

Oflono-3




Oflono-3 may be available in the countries listed below.


Ingredient matches for Oflono-3



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Oflono-3 in the following countries:


  • Chile

International Drug Name Search


Doxorubicin Hydrochloride-Shantou Meiji




Doxorubicin Hydrochloride-Shantou Meiji may be available in the countries listed below.


Ingredient matches for Doxorubicin Hydrochloride-Shantou Meiji



Doxorubicin

Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Doxorubicin Hydrochloride-Shantou Meiji in the following countries:


  • China

International Drug Name Search


Dilt-CD




Ingredient matches for Dilt-CD



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Dilt-CD in the following countries:


  • United States

International Drug Name Search


Monday, October 24, 2016

Aczone


Aczone is a brand name of dapsone topical, approved by the FDA in the following formulation(s):


ACZONE (dapsone - gel; topical)



  • Manufacturer: ALLERGAN

    Approval date: July 7, 2005

    Strength(s): 5% [RLD]

Has a generic version of Aczone been approved?


No. There is currently no therapeutically equivalent version of Aczone available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aczone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Compositions and methods for topical application of therapeutic agents
    Patent 5,863,560
    Issued: January 26, 1999
    Inventor(s): Osborne; David W.
    Assignee(s): ViroTex Corporation
    The present invention generally relates to pharmaceutical compositions that enable control of drug delivery properties and the development of optimal drug delivery strategies customized for particular drugs and particular diseases. The composition includes a dissolved pharmaceutical that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a pharmaceutical in a microparticulate state that does not readily cross the stratum corneum of the epidermis. The dissolved and microparticulate pharmaceuticals may be the same or different pharmaceuticals. Methods for the preparation and use of the compositions are also provided. In a preferred embodiment, the invention finds particular use in a formulation for the topical application of dapsone for the treatment of acne. In another preferred embodiment, the invention finds particular use for the treatment of herpes lesions.
    Patent expiration dates:

    • September 11, 2016
      ✓ 
      Drug product




  • Compositions and methods for topical application of therapeutic agents
    Patent 6,060,085
    Issued: May 9, 2000
    Inventor(s): Osborne; David W.
    The present invention generally relates to pharmaceutical compositions that enable control of drug delivery properties and the development of optimal drug delivery strategies customized for particular drugs and particular diseases. The composition includes a dissolved pharmaceutical that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a pharmaceutical in a microparticulate state that does not readily cross the stratum corneum of the epidermis. The dissolved and microparticulate pharmaceuticals may be the same or different pharmaceuticals. Methods for the preparation and use of the compositions are also provided. In a preferred embodiment, the invention finds particular use in a formulation for the topical application of dapsone for the treatment of acne. In another preferred embodiment, the invention finds particular use for the treatment of herpes lesions.
    Patent expiration dates:

    • September 11, 2016
      ✓ 
      Patent use: TREATMENT OF ACNE




  • Compositions for topical application of therapeutic agents
    Patent 6,620,435
    Issued: September 16, 2003
    Inventor(s): David W.; Osborne
    Assignee(s): ViroTex Corporation
    The present invention generally relates to pharmaceutical compositions that enable control of drug, delivery properties and the development of optimal drug delivery strategies customized for particular drugs and particular diseases. The composition includes a dissolved pharmaceutical that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a pharmaceutical in a microparticulate state that does not readily cross the stratum corneum of the epidermis. The dissolved and microparticulate pharmaceuticals may be the same or different pharmaceuticals. Methods for the preparation and use of the compositions are also provided. In a preferred embodiment, the invention finds particular use in a formulation for the topical application of dapsone for the treatment of acne. In another preferred embodiment, the invention finds particular use for the treatment of herpes lesions.
    Patent expiration dates:

    • September 11, 2016
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 14, 2011 - REMOVAL OF SCREEN REQUIREMENT IN PTS WITH G6PD DEFICIENCY PRIOR TO INITIATING ACZONE TREATMENT; REMOVAL OF BLOOD COUNT & RETICULOCYTE MONITORING DURING TREATMENT IN G6PD DEFICIENT PTS AND IN PATIENTS WITH HISTORY OF ANEMIA

See also...

  • Aczone Consumer Information (Drugs.com)
  • Aczone Gel Consumer Information (Wolters Kluwer)
  • Aczone Consumer Information (Cerner Multum)
  • Aczone Topical Advanced Consumer Information (Micromedex)
  • Aczone topical AHFS DI Monographs (ASHP)
  • Dapsone Gel Consumer Information (Wolters Kluwer)
  • Dapsone topical Consumer Information (Cerner Multum)
  • Dapsone Topical Advanced Consumer Information (Micromedex)
  • Dapsone topical AHFS DI Monographs (ASHP)

Hevic




Hevic may be available in the countries listed below.


Ingredient matches for Hevic



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Hevic in the following countries:


  • Japan

International Drug Name Search


Diclofenac Adico




Diclofenac Adico may be available in the countries listed below.


Ingredient matches for Diclofenac Adico



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclofenac Adico in the following countries:


  • Switzerland

International Drug Name Search


Notorium




Notorium may be available in the countries listed below.


Ingredient matches for Notorium



Bromazepam

Bromazepam is reported as an ingredient of Notorium in the following countries:


  • Greece

  • Malta

International Drug Name Search


Diacereina




Diacereina may be available in the countries listed below.


Ingredient matches for Diacereina



Diacerein

Diacereina (DCIT) is also known as Diacerein (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Vidibion




Vidibion may be available in the countries listed below.


Ingredient matches for Vidibion



Potassium Iodide

Potassium Iodide is reported as an ingredient of Vidibion in the following countries:


  • Poland

Sodium Iodide

Sodium Iodide is reported as an ingredient of Vidibion in the following countries:


  • Poland

International Drug Name Search


Nuelin




Nuelin may be available in the countries listed below.


UK matches:

  • Nuelin SA Tablets
  • Nuelin SA 175 mg Tablets (SPC)
  • Nuelin SA 250 mg Tablets (SPC)

Ingredient matches for Nuelin



Theophylline

Theophylline is reported as an ingredient of Nuelin in the following countries:


  • Australia

  • Dominican Republic

  • El Salvador

  • Finland

  • Guatemala

  • Honduras

  • Malaysia

  • New Zealand

  • Norway

  • Oman

  • Panama

  • Philippines

  • Singapore

  • South Africa

  • Sri Lanka

  • Venezuela

Theophylline monohydrate (a derivative of Theophylline) is reported as an ingredient of Nuelin in the following countries:


  • United Kingdom

Theophylline

Theophylline Sodium Glycinate is reported as an ingredient of Nuelin in the following countries:


  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Panama

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sonifilan




Sonifilan may be available in the countries listed below.


Ingredient matches for Sonifilan



Sizofiran

Sizofiran is reported as an ingredient of Sonifilan in the following countries:


  • Japan

International Drug Name Search


Sunday, October 23, 2016

Halopredone Acetate




Halopredone Acetate may be available in the countries listed below.


Ingredient matches for Halopredone Acetate



Halopredone

Halopredone Acetate (JAN, USAN) is also known as Halopredone (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Zolpidem Cinfa




Zolpidem Cinfa may be available in the countries listed below.


Ingredient matches for Zolpidem Cinfa



Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolpidem Cinfa in the following countries:


  • Portugal

  • Spain

International Drug Name Search


Soluirubin




Soluirubin may be available in the countries listed below.


Ingredient matches for Soluirubin



Zaltoprofen

Zaltoprofen is reported as an ingredient of Soluirubin in the following countries:


  • Japan

International Drug Name Search


Valproate de sodium Ratiopharm




Valproate de sodium Ratiopharm may be available in the countries listed below.


Ingredient matches for Valproate de sodium Ratiopharm



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valproate de sodium Ratiopharm in the following countries:


  • France

International Drug Name Search


Spironolacton Aristo




Spironolacton Aristo may be available in the countries listed below.


Ingredient matches for Spironolacton Aristo



Spironolactone

Spironolactone is reported as an ingredient of Spironolacton Aristo in the following countries:


  • Germany

International Drug Name Search


Nora




Nora may be available in the countries listed below.


Ingredient matches for Nora



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Nora in the following countries:


  • Belgium

Levonorgestrel

Levonorgestrel is reported as an ingredient of Nora in the following countries:


  • Belgium

International Drug Name Search


Dentisept




Dentisept may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dentisept



Chlorhexidine

Chlorhexidine is reported as an ingredient of Dentisept in the following countries:


  • Austria

  • Germany

  • Switzerland

International Drug Name Search


Saturday, October 22, 2016

Despigmentante




Despigmentante may be available in the countries listed below.


Ingredient matches for Despigmentante



Hydroquinone

Hydroquinone is reported as an ingredient of Despigmentante in the following countries:


  • Peru

International Drug Name Search


Quilonum




Quilonum may be available in the countries listed below.


Ingredient matches for Quilonum



Lithium

Lithium acetate (a derivative of Lithium) is reported as an ingredient of Quilonum in the following countries:


  • Germany

Lithium carbonate (a derivative of Lithium) is reported as an ingredient of Quilonum in the following countries:


  • Australia

  • South Africa

International Drug Name Search


Norvis




Norvis may be available in the countries listed below.


Ingredient matches for Norvis



Tiemonium Methylsulfate

Tiemonium Methylsulfate is reported as an ingredient of Norvis in the following countries:


  • Bangladesh

International Drug Name Search


Slo-Niacin




In the US, Slo-Niacin (niacin systemic) is a member of the following drug classes: miscellaneous antihyperlipidemic agents, vitamins and is used to treat High Cholesterol, Hyperlipoproteinemia, Hyperlipoproteinemia Type IV - Elevated VLDL, Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL, Niacin Deficiency and Pellagra.

US matches:

  • Slo-Niacin Controlled-Release Capsules

  • Slo-Niacin nicotinic acid

  • Slo-Niacin

Ingredient matches for Slo-Niacin



Nicotinic Acid

Nicotinic Acid is reported as an ingredient of Slo-Niacin in the following countries:


  • United States

International Drug Name Search


K-V Pharmaceutical Company


Address


K-V Pharmaceutical Company,
2503 South Hanley Road

St. Louis, MO 63144

Contact Details

Phone: (314) 645-6600
Website: http://www.kvpharma.com
Careers: http://www.kvpharma.com/careers_landing.aspx

Nalidixic Acid




In some countries, this medicine may only be approved for veterinary use.


In the US, Nalidixic Acid (nalidixic acid systemic) is a member of the following drug classes: quinolones, urinary anti-infectives and is used to treat Bladder Infection and Prevention of Bladder infection.

US matches:

  • Nalidixic Acid

  • Nalidixic Acid Suspension

UK matches:

  • Nalidixic Acid 300mg/5ml Oral Suspension
  • Nalidixic Acid 300mg/5ml Oral Suspension (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MB02

CAS registry number (Chemical Abstracts Service)

0000389-08-2

Chemical Formula

C12-H12-N2-O3

Molecular Weight

232

Therapeutic Category

Antiinfective, quinolin-derivative

Chemical Name

1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-

Foreign Names

  • Acidum Nalidixicum (Latin)
  • Nalidixinsäure (German)
  • Acide nalidixique (French)
  • Acido nalidixico (Spanish)

Generic Names

  • Acide nalidixique (OS: DCF)
  • Acido nalidixico (OS: DCIT)
  • Nalidixic Acid (OS: BAN, USAN)
  • Win 18320 (IS)
  • Acidum nalidixicum (PH: Ph. Eur. 6)
  • Nalidixic Acid (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
  • Nalidixinsäure (PH: Ph. Eur. 6)
  • Nalidixique (acide) (PH: Ph. Eur. 6)

Brand Names

  • Acido Nalidixico L.CH.
    Chile, Chile


  • Acido Nalidixico
    Prodes, Oman


  • Degram
    Doctor's Chemical Work, Bangladesh


  • Diarlop
    Jagson Pal, India


  • Dixicon
    Jayson, Bangladesh


  • Gramazine
    Johnson, Taiwan


  • Gramoneg
    Ranbaxy, India


  • Nal-acid
    Farmanic Chemipharma, Greece


  • Naldix
    Shiba, Yemen


  • Nalid
    Square, Bangladesh


  • Nalidix
    Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Jordan; Dar-Al-Dawa, Kuwait; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Qatar; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Somalia; Dar-Al-Dawa, Tunisia; Dar-Al-Dawa, Yemen


  • Nalidixic Acid Malpharm
    International Medical, Hong Kong; Malaysia Chemist, Singapore


  • Nalidixic Acid
    Remedica, Cyprus; Watson, United States


  • Naligram
    Acme, Bangladesh; Acme, Sri Lanka


  • Nalix
    Aristopharma, Bangladesh


  • Nalixid
    Zentiva, Romania


  • Nebactil
    Beximco, Bangladesh


  • Negadix
    CFL, India


  • NegGram
    Sanofi-Aventis, United States


  • Negram
    Sanofi-Aventis, Bahrain; Sanofi-Aventis, Egypt; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Cyprus; Sanofi-Synthelabo, Ireland; Sanofi-Synthelabo, Jordan


  • Negram (veterinary use)
    Sanofi-Synthelabo, United Kingdom


  • Nelidix
    Actavis, Georgia


  • Nevigramon
    Chinoin, Poland; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hungary


  • Puromylon
    Aspen Pharmacare, South Africa


  • Ultragam
    Globe, Bangladesh


  • Unaserus
    Isei, Japan


  • Uriben
    Rosemont, United Kingdom


  • Uriben (veterinary use)
    Rosemont, United Kingdom


  • Urineg
    Armoxindo, Indonesia


  • Urotan
    Markos, Peru


  • Utirex
    Opsonin, Bangladesh


  • Winlomylon
    Adcock Ingram Pharmaceuticals, South Africa


  • Wintomilon
    Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal


  • Wintomylon
    Nipro PatchNipuropatchi, Japan; Sanofi-Aventis, Brazil; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Hong Kong; Sanofi-Synthelabo, Peru


  • Wintomylon (pediatric)
    Daiichi Sankyo, Japan


  • Wintorin
    Sankei Yakuhin, Japan


  • Youdix
    Yoshindo, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Domifene bromuro




Domifene bromuro may be available in the countries listed below.


Ingredient matches for Domifene bromuro



Domiphen Bromide

Domifene bromuro (DCIT) is also known as Domiphen Bromide (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, October 21, 2016

Difluzol




Difluzol may be available in the countries listed below.


Ingredient matches for Difluzol



Fluconazole

Fluconazole is reported as an ingredient of Difluzol in the following countries:


  • Austria

  • Peru

  • Tunisia

International Drug Name Search


Orocil




Orocil may be available in the countries listed below.


Ingredient matches for Orocil



Benzoxonium Chloride

Benzoxonium Chloride is reported as an ingredient of Orocil in the following countries:


  • Greece

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Orocil in the following countries:


  • Greece

International Drug Name Search


Winter Dip




Winter Dip may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Winter Dip



Dimpylate

Dimpylate is reported as an ingredient of Winter Dip in the following countries:


  • Ireland

International Drug Name Search


Nasochrom




Nasochrom may be available in the countries listed below.


Ingredient matches for Nasochrom



Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Nasochrom in the following countries:


  • Bangladesh

International Drug Name Search


Uterone




Uterone may be available in the countries listed below.


Ingredient matches for Uterone



Tibolone

Tibolone is reported as an ingredient of Uterone in the following countries:


  • India

International Drug Name Search


Cozaar


Cozaar is a brand name of losartan, approved by the FDA in the following formulation(s):


COZAAR (losartan potassium - tablet; oral)



  • Manufacturer: MERCK

    Approval date: April 14, 1995

    Strength(s): 25MG [AB], 50MG [AB]


  • Manufacturer: MERCK

    Approval date: October 13, 1998

    Strength(s): 100MG [RLD][AB]

Has a generic version of Cozaar been approved?


Yes. The following products are equivalent to Cozaar:


losartan potassium tablet; oral



  • Manufacturer: ACTAVIS INC

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: ALEMBIC PHARMS LTD

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: APOTEX CORP

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: AUROBINDO PHARMA

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: LUPIN LTD

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: MYLAN

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: PRINSTON INC

    Approval date: June 6, 2011

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: ROXANE

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: SANDOZ

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: TEVA

    Approval date: April 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: TORRENT PHARMS

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: UPSHER SMITH

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]


  • Manufacturer: ZYDUS PHARMS USA INC

    Approval date: October 6, 2010

    Strength(s): 100MG [AB], 25MG [AB], 50MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cozaar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cozaar.

See also...

  • Cozaar Consumer Information (Drugs.com)
  • Cozaar Consumer Information (Wolters Kluwer)
  • Cozaar Consumer Information (Cerner Multum)
  • Cozaar Advanced Consumer Information (Micromedex)
  • Cozaar AHFS DI Monographs (ASHP)
  • Losartan Consumer Information (Wolters Kluwer)
  • Losartan Consumer Information (Cerner Multum)
  • Losartan Advanced Consumer Information (Micromedex)
  • Losartan Potassium AHFS DI Monographs (ASHP)

Loestrin 21 1.5 / 30


See also: Generic Loestrin 21 1/20, Generic Loestrin 24 Fe, Generic Loestrin Fe 1.5/30, Generic Loestrin Fe 1/20


Loestrin 21 1.5/30 is a brand name of ethinyl estradiol/norethindrone, approved by the FDA in the following formulation(s):


LOESTRIN 21 1.5/30 (ethinyl estradiol; norethindrone acetate - tablet; oral-21)



  • Manufacturer: WARNER CHILCOTT

    Approved Prior to Jan 1, 1982

    Strength(s): 0.03MG;1.5MG [AB]

Has a generic version of Loestrin 21 1.5/30 been approved?


Yes. The following products are equivalent to Loestrin 21 1.5/30:


JUNEL 1.5/30 (ethinyl estradiol; norethindrone acetate tablet; oral-21)



  • Manufacturer: BARR

    Approval date: May 30, 2003

    Strength(s): 0.03MG;1.5MG [AB]

MICROGESTIN 1.5/30 (ethinyl estradiol; norethindrone acetate tablet; oral-21)



  • Manufacturer: WATSON LABS

    Approval date: July 30, 2003

    Strength(s): 0.03MG;1.5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Loestrin 21 1.5/30. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Loestrin 21 1.5/30.

See also...

  • Loestrin 21 1.5/30 Consumer Information (Cerner Multum)
  • Ortho-Novum Consumer Information (Drugs.com)
  • Norethindrone/Ethinyl Estradiol Consumer Information (Wolters Kluwer)
  • Norethindrone/Ethinyl Estradiol (HRT) Consumer Information (Wolters Kluwer)
  • Norethindrone/Ethinyl Estradiol Chewable Tablets Consumer Information (Wolters Kluwer)
  • Norethindrone/Ethinyl Estradiol Tablets Consumer Information (Wolters Kluwer)
  • Ethinyl estradiol and norethindrone Consumer Information (Cerner Multum)
  • Ethinyl estradiol and norethindrone HRT Consumer Information (Cerner Multum)
  • Norethindrone, ethinyl estradiol, and ferrous fumarate Advanced Consumer Information (Micromedex)

Miscellaneous ophthalmic agents


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

The ophthalmic preparation categorized under miscellaneous ophthalmic agents is an antimydriatic agent, which decreases the size of the pupil. It is available as a solution and instilled into the eyes to decrease the size of the pupil after eye examinations or procedures (prior to which mydriatic agents are used to dilate the pupil, in order to examine the eye).

See also

Medical conditions associated with miscellaneous ophthalmic agents:

  • Eye Dryness/Redness

Drug List:


Questran Light




In the US, Questran Light (cholestyramine systemic) is a member of the drug class bile acid sequestrants and is used to treat Crohn's Disease, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Irritable Bowel Syndrome and Pruritus of Partial Biliary Obstruction.

US matches:

  • Questran Light

Ingredient matches for Questran Light



Colestyramine

Colestyramine is reported as an ingredient of Questran Light in the following countries:


  • Argentina

  • Brazil

  • Singapore

  • Thailand

International Drug Name Search


Thursday, October 20, 2016

Udrik




Udrik may be available in the countries listed below.


Ingredient matches for Udrik



Trandolapril

Trandolapril is reported as an ingredient of Udrik in the following countries:


  • Germany

  • Luxembourg

International Drug Name Search


Sonke-Zidovudine




Sonke-Zidovudine may be available in the countries listed below.


Ingredient matches for Sonke-Zidovudine



Zidovudine

Zidovudine is reported as an ingredient of Sonke-Zidovudine in the following countries:


  • South Africa

International Drug Name Search


Ventolin Diskus




Ventolin Diskus may be available in the countries listed below.


Ingredient matches for Ventolin Diskus



Salbutamol

Salbutamol is reported as an ingredient of Ventolin Diskus in the following countries:


  • Ireland

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Ventolin Diskus in the following countries:


  • Czech Republic

  • Iceland

  • Israel

  • Luxembourg

  • Romania

International Drug Name Search


Synarela




Synarela may be available in the countries listed below.


Ingredient matches for Synarela



Nafarelin

Nafarelin acetate (a derivative of Nafarelin) is reported as an ingredient of Synarela in the following countries:


  • Denmark

  • Finland

  • Germany

  • Iceland

  • Norway

  • Sweden

International Drug Name Search


Sili Met San




Sili Met San may be available in the countries listed below.


Ingredient matches for Sili Met San



Calcium Pantothenate

Calcium Pantothenate is reported as an ingredient of Sili Met San in the following countries:


  • Belgium

Dimeticone

Dimeticone is reported as an ingredient of Sili Met San in the following countries:


  • Belgium

International Drug Name Search


Séglor




Séglor may be available in the countries listed below.


Ingredient matches for Séglor



Dihydroergotamine

Dihydroergotamine mesilate (a derivative of Dihydroergotamine) is reported as an ingredient of Séglor in the following countries:


  • France

International Drug Name Search


Nene-Lax




Nene-Lax may be available in the countries listed below.


Ingredient matches for Nene-Lax



Glycerol

Glycerol is reported as an ingredient of Nene-Lax in the following countries:


  • Germany

International Drug Name Search


Nicotinyl Alcohol Tartrate




Nicotinyl Alcohol Tartrate may be available in the countries listed below.


Ingredient matches for Nicotinyl Alcohol Tartrate



Nicotinyl Alcohol

Nicotinyl Alcohol Tartrate (BANM) is also known as Nicotinyl Alcohol (USAN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Dolpyc




Dolpyc may be available in the countries listed below.


Ingredient matches for Dolpyc



Capsaicin

Capsaicin is reported as an ingredient of Dolpyc in the following countries:


  • Italy

International Drug Name Search


Dozasin




Dozasin may be available in the countries listed below.


Ingredient matches for Dozasin



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Dozasin in the following countries:


  • Romania

International Drug Name Search


Sevoness




Sevoness may be available in the countries listed below.


Ingredient matches for Sevoness



Sevoflurane

Sevoflurane is reported as an ingredient of Sevoness in the following countries:


  • Japan

International Drug Name Search


Wednesday, October 19, 2016

Heparin Sodium Injection




Heparin Sodium Injection may be available in the countries listed below.


Ingredient matches for Heparin Sodium Injection



Heparin

Heparin sodium salt (a derivative of Heparin) is reported as an ingredient of Heparin Sodium Injection in the following countries:


  • Australia

  • Canada

  • New Zealand

International Drug Name Search


Zyrova




Zyrova may be available in the countries listed below.


Ingredient matches for Zyrova



Rosuvastatin

Rosuvastatin is reported as an ingredient of Zyrova in the following countries:


  • Myanmar

International Drug Name Search


Dolana




Dolana may be available in the countries listed below.


Ingredient matches for Dolana



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Dolana in the following countries:


  • Indonesia

International Drug Name Search


Nitrazepam




UK matches:

  • Nitrazepam Tablets 5mg (Actavis UK Ltd)
  • Nitrazepam Mixture BP (SOMNITE Suspension) (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05CD02

CAS registry number (Chemical Abstracts Service)

0000146-22-5

Chemical Formula

C15-H11-N3-O3

Molecular Weight

281

Therapeutic Categories

Antiepileptic agent

Benzodiazepine derivative

Hypnotic agent

Chemical Name

2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-

Foreign Names

  • Nitrazepamum (Latin)
  • Nitrazepam (German)
  • Nitrazépam (French)
  • Nitrazepam (Spanish)

Generic Names

  • Nitrazepam (OS: USAN, JAN, DCIT, BAN)
  • Nitrazépam (OS: DCF)
  • LA 1 (IS)
  • Ro 45360 (IS)
  • Ro 53059 (IS: Roche)
  • Nitrazepam (PH: JP XIV, Ph. Int. 4, Ph. Eur. 6, BP 2010)
  • Nitrazépam (PH: Ph. Eur. 6)
  • Nitrazepamum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Alodorm
    Alphapharm, Australia


  • Apodorm
    Actavis, Norway; Actavis, Sweden; Alpharma ASNO, Denmark


  • Apo-Nitrazepam
    Apotex, Canada


  • Benzalin
    Shionogi Seiyaku, Japan


  • Cerson
    Belupo, Bosnia & Herzegowina; Belupo, Croatia (Hrvatska); Belupo, Serbia; Belupo, Slovenia


  • Cysvon
    Tsuruhara Seiyaku, Japan


  • Dormo-Puren
    Actavis, Germany


  • Dumolid
    Actavis, Indonesia


  • Epam
    Opsonin, Bangladesh


  • Eunoctin
    Gedeon Richter, Hungary; Gedeon Richter, Lithuania


  • Hirusukamin
    Isei, Japan


  • Hypnotex
    Pharmaceutical Co, India


  • Imeson
    Taurus, Germany


  • Insomin
    Orion, Finland


  • Mogadan
    Valeant, Germany


  • Mogadon
    ICN, Iceland; ICN, Luxembourg; Meda, Belgium; Meda, Switzerland; Meda, France; Meda, Ireland; Meda, Sweden; Meda AS, Denmark; Pharmaco, South Africa; Valeant, Austria; Valeant, Australia; Valeant, Canada; Valeant, Hong Kong; Valeant, Italy; Valeant, Malta; Valeant, Netherlands; Valeant, Norway; Valeant, Taiwan


  • Nelbon
    Daiichi Sankyo, Japan


  • Nelurolen
    Tatsumi Kagaku, Japan


  • Neuchlonic
    Taiyo Pharmaceutical, Japan


  • Nipam
    Bosnalijek, Serbia


  • Nitavan
    Stadmed, India


  • Nitrados
    Douglas, New Zealand; Douglas, Singapore


  • Nitravet
    Anglo-French, India


  • Nitrazadon
    Valeant, Canada


  • Nitrazepam A
    Apothecon, Netherlands


  • Nitrazepam AccordHealthcare
    Accord Healthcare, Netherlands


  • Nitrazepam Actavis
    Actavis, Netherlands


  • Nitrazepam AL
    Aliud, Germany


  • Nitrazepam CF
    Centrafarm, Netherlands


  • Nitrazepam Dak
    Nycomed, Denmark


  • Nitrazepam GenRx
    GenRx, Netherlands


  • Nitrazepam Katwijk
    Apotex Europe, Netherlands


  • Nitrazepam LPH
    Labormed Pharma, Romania


  • Nitrazepam Merck
    Mylan, Netherlands


  • Nitrazepam PCH
    Pharmachemie, Netherlands


  • Nitrazepam ratiopharm
    ratiopharm, Netherlands


  • Nitrazepam Recip
    Recip, Sweden


  • Nitrazepam Sandoz
    Sandoz, Netherlands


  • Nitrazepam Slovakofarma
    Zentiva, Czech Republic


  • Nitrazepam Teva
    Teva, Belgium


  • Nitrazepam Zizhu Pharm
    Zizhu, China


  • Nitrazepam
    Actavis, United Kingdom; CP, Malta; Gedeon Richter, Romania; GlaxoSmithKline, Poland; Norgine, United Kingdom; Wise, Netherlands; Wockhardt, United Kingdom


  • Nitrazepam-neuraxpharm
    Neuraxpharm, Germany


  • Nitrazepol
    Farmasa, Brazil


  • Nitredon
    Remedica, Cyprus; Remedica, Kenya; Remedica, Malta; Remedica, Sudan; Remedica, Zimbabwe


  • Nitrosun
    Sun, India


  • Novanox
    Pfleger, Germany


  • Numbon
    Teva, Israel


  • Octon
    Gaco, Bangladesh


  • Onirema
    Biotech, Venezuela


  • Pacisyn
    DLF, Denmark


  • Racedorm
    AWD Pharma, Estonia


  • Radedorm
    AWD, Bulgaria; AWD.pharma, Germany; AWD.pharma, Lithuania; AWD.pharma, Latvia; Pliva, Russian Federation


  • Sandoz Nitrazepam
    Sandoz, Canada; Sandoz, South Africa


  • Somnite
    Norgine, United Arab Emirates; Norgine, Bahrain; Norgine, Cyprus; Norgine, Iraq; Norgine, Jordan; Norgine, Kuwait; Norgine, Lebanon; Norgine, Libya; Norgine, Qatar; Norgine, Saudi Arabia; Norgine, Sudan


  • Trazem
    Bosnalijek, Bosnia & Herzegowina

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Norfloxacine EG




Norfloxacine-EG may be available in the countries listed below.


Ingredient matches for Norfloxacine-EG



Norfloxacin

Norfloxacin is reported as an ingredient of Norfloxacine-EG in the following countries:


  • Belgium

  • France

  • Luxembourg

International Drug Name Search


DepoCyte




DepoCyte may be available in the countries listed below.


UK matches:

  • DepoCyte 50 mg suspension for injection
  • DepoCyte 50 mg suspension for injection (SPC)

Ingredient matches for DepoCyte



Cytarabine

Cytarabine is reported as an ingredient of DepoCyte in the following countries:


  • Austria

  • Belgium

  • Denmark

  • Finland

  • France

  • Germany

  • Iceland

  • Italy

  • Luxembourg

  • Netherlands

  • Norway

  • Poland

  • Slovakia

  • Slovenia

  • Spain

  • Sweden

  • Switzerland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Normotherin




Normotherin may be available in the countries listed below.


Ingredient matches for Normotherin



Simvastatin

Simvastatin is reported as an ingredient of Normotherin in the following countries:


  • Greece

International Drug Name Search


Hemodorm




Hemodorm may be available in the countries listed below.


Ingredient matches for Hemodorm



Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Hemodorm in the following countries:


  • Germany

International Drug Name Search


Norflex


Norflex is a brand name of orphenadrine, approved by the FDA in the following formulation(s):


NORFLEX (orphenadrine citrate - injectable; injection)



  • Manufacturer: MEDICIS

    Approved Prior to Jan 1, 1982

    Strength(s): 30MG/ML [RLD][AP]

Has a generic version of Norflex been approved?


Yes. The following products are equivalent to Norflex:


orphenadrine citrate injectable; injection



  • Manufacturer: AKORN

    Approval date: May 24, 2006

    Strength(s): 30MG/ML [AP]


  • Manufacturer: BEDFORD LABS

    Approval date: March 4, 2003

    Strength(s): 30MG/ML [AP]


  • Manufacturer: SAGENT PHARMS

    Approval date: August 30, 2011

    Strength(s): 30MG/ML [AP]


  • Manufacturer: WATSON LABS

    Approved Prior to Jan 1, 1982

    Strength(s): 30MG/ML [AP]


  • Manufacturer: WATSON LABS

    Approval date: March 15, 1982

    Strength(s): 30MG/ML [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Norflex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Norflex.

See also...

  • Norflex Consumer Information (Wolters Kluwer)
  • Norflex Consumer Information (Cerner Multum)
  • Norflex Advanced Consumer Information (Micromedex)
  • Norflex Injection Advanced Consumer Information (Micromedex)
  • Norflex AHFS DI Monographs (ASHP)
  • Orphenadrine Consumer Information (Wolters Kluwer)
  • Orphenadrine Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Orphenadrine Consumer Information (Cerner Multum)
  • Orphenadrine Advanced Consumer Information (Micromedex)
  • Orphenadrine Injection Advanced Consumer Information (Micromedex)
  • Orphenadrine Citrate AHFS DI Monographs (ASHP)

Winol




Winol may be available in the countries listed below.


Ingredient matches for Winol



Irinotecan

Irinotecan hydrochloride trihydrate (a derivative of Irinotecan) is reported as an ingredient of Winol in the following countries:


  • Argentina

International Drug Name Search


Vasorel




Vasorel may be available in the countries listed below.


Ingredient matches for Vasorel



Trimetazidine

Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Vasorel in the following countries:


  • China

International Drug Name Search


Tuesday, October 18, 2016

Dienestrol




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G03CB01,G03CC02

CAS registry number (Chemical Abstracts Service)

0000084-17-3

Chemical Formula

C18-H18-O2

Molecular Weight

266

Therapeutic Category

Estrogen

Chemical Name

Phenol, 4,4'-(1,2-diethylidene-1,2-ethanediyl)bis-

Foreign Names

  • Dienestrolum (Latin)
  • Dienestrol (German)
  • Diènestrol (French)
  • Dienestrol (Spanish)

Generic Names

  • Dienestrol (OS: BAN)
  • Diènestrol (OS: DCF)
  • Dienestrolo (OS: DCIT)
  • Dienoestrol (IS)
  • Hexadienestrol (IS)
  • Dienestrol (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Diènestrol (PH: Ph. Eur. 6)
  • Dienestrolum (PH: Ph. Int. 2, Ph. Eur. 6)

Brand Names

  • Ortho Dienestrol
    Ortho-McNeil, United States


  • Ortho Dienoestrol
    Janssen, Lebanon; Janssen, Sudan; Janssen, Syria; Janssen, Yemen; Janssen-Cilag, Egypt

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sulfinpyrazone




In the US, Sulfinpyrazone (sulfinpyrazone systemic) is a member of the drug class antigout agents and is used to treat Gouty Arthritis.

US matches:

  • Sulfinpyrazone

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M04AB02

CAS registry number (Chemical Abstracts Service)

0000057-96-5

Chemical Formula

C23-H20-N2-O3-S

Molecular Weight

404

Therapeutic Category

Uricosuric agent

Chemical Name

3,5-Pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-

Foreign Names

  • Sulfinpyrazonum (Latin)
  • Sulfinpyrazon (German)
  • Sulfinpyrazone (French)
  • Sulfinpirazona (Spanish)

Generic Names

  • Sulfinpirazone (OS: DCIT)
  • Sulfinpyrazone (OS: JAN, DCF, BAN)
  • G 28315 (IS)
  • Sulphinpyrazone (IS)
  • Sulfinpyrazon (PH: Ph. Eur. 6)
  • Sulfinpyrazone (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
  • Sulfinpyrazonum (PH: Ph. Eur. 6)

Brand Names

  • Anturan
    Amdipharm, United Kingdom; Cisuba, Sudan; Heko, Tanzania; Lindsay-Chemie, Zimbabwe; Medview, Ghana; Novartis, Guyana; Novartis, Israel; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria


  • Anturane
    Novartis, United States


  • Apo-Sulfinpyrazone
    Apotex, Canada


  • Enturen
    Medivis, Italy


  • Sulfin
    TTY Biopharm, Taiwan

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.